Amarantus Bioscience Holdings Inc (AMBS)

[tsuguy]

The better news is big pharma will likely be the one dictating which test will be commercialized initially. With near certainty one would think AMBS will be meeting with those pharma's to ask them which test they would like to use. This almost is conviction on getting test introduced into their screening. Which means sales pipeline immediately!

At that time I would think many pharma's will be asking price of individual test and price for LymPro as a stand alone sale. They may even be taking orders now based on commercialization launch window. Marketing/sales works in many ways!

Gerald and team wants this to happen soon and I think they are pushing everything they can to make big announcement before the end of the year. As it was stated, he has bonuses tied to key elements of performance.